Pegylated (40kDa) interferon alfa-2a (PEGASYS®) in combination with ribavirin: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study
Authors:
- Michael W. FriedMFMichael W. Fried
- Mitchell L. ShiffmanMSMitchell L. Shiffman
- Rejender K. ReddyRRRejender K. Reddy
- Coleman SmithCSColeman Smith
- George MarinoGMGeorge Marino
- Femando GoncalesFGFemando Goncales
- Dieter HaeussingerDHDieter Haeussinger
- Moises DiagoMDMoises Diago
- Giampietro CaroslGCGiampietro Carosl
- Jean-Pierre ZarskiJZJean-Pierre Zarski
- Joseph HoffmanJHJoseph Hoffman
- Jian YuJYJian Yu
- 1 April 2001
- journal article
- abstracts
- Published by Elsevier in Gastroenterology
- Vol. 120 (5) , A55